Corazon Sanders
Director/Miembro de la Junta en LEGEND BIOTECH CORPORATION .
Fortuna: 2 M $ al 31/12/2024
Perfil
Corazon Dating Sanders is currently serving as a Director at AbGenomics International, Inc. Additionally, Sanders holds current positions as an Independent Director at Ultragenyx Pharmaceutical, Inc., an Independent Non-Executive Director at BeiGene Ltd., an Independent Director at Legend Biotech Corp., and a Director at Altrubio, Inc. Previously, Sanders worked as a Director at the Fred Hutchinson Cancer Research Center and Transcelerate Biopharma, Inc. Sanders also served as an Independent Director at Molecular Templates, Inc. from 2019 to 2024.
Prior to that, Sanders held the position of Senior Vice President & Global Head-PD Innovation at Genentech, Inc. from 2012 to 2017.
Sanders was also the Executive Vice President-Development Operations at Juno Therapeutics, Inc. from 2017 to 2018.
In terms of education, Sanders completed undergraduate and graduate studies at the University of the Philippines.
Sanders also obtained graduate and doctorate degrees from The Wharton School of the University of Pennsylvania.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
BEIGENE LTD
0 % | 05/06/2024 | 46 241 ( 0 % ) | 650 045 $ | 31/12/2024 |
02/07/2024 | 12 009 ( 0,01 % ) | 505 219 $ | 31/12/2024 | |
LEGEND BIOTECH CORP.
0,01 % | 31/12/2023 | 28 885 ( 0,01 % ) | 469 959 $ | 31/12/2024 |
27/09/2024 | 0 ( -.--% ) | - $ | 31/12/2024 |
Últimas noticias acerca de Corazon Sanders
Cargos activos de Corazon Sanders
Empresas | Cargo | Inicio |
---|---|---|
LEGEND BIOTECH CORPORATION | Director/Miembro de la Junta | 01/05/2020 |
BEIGENE, LTD. | Director/Miembro de la Junta | 24/08/2020 |
ULTRAGENYX PHARMACEUTICAL INC. | Director/Miembro de la Junta | 29/06/2021 |
AbGenomics International, Inc.
![]() AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Director/Miembro de la Junta | - |
Altrubio, Inc.
![]() Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Director/Miembro de la Junta | 01/03/2020 |
Antiguos cargos conocidos de Corazon Sanders.
Empresas | Cargo | Fin |
---|---|---|
MOLECULAR TEMPLATES, INC. | Director/Miembro de la Junta | 31/12/2024 |
JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/03/2018 |
Genentech, Inc.
![]() Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director Administrativo | 29/08/2012 |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Miembro de la Junta | 02/01/2016 |
░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Corazon Sanders.
University of the Philippines | Graduate Degree |
The Wharton School of the University of Pennsylvania | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
LEGEND BIOTECH CORPORATION | Health Technology |
BEIGENE, LTD. | Health Technology |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
Empresas privadas | 6 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Juno Therapeutics, Inc.
![]() Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Fred Hutchinson Cancer Research Center
![]() Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
AbGenomics International, Inc.
![]() AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Health Technology |
Altrubio, Inc.
![]() Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Retail Trade |
- Bolsa de valores
- Insiders
- Corazon Sanders